10-K Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001564590-19-022300`
Period End Date	20190331
Filing Date	20190612
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	tyme-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 92 Cash Flow Statement 50 Stockholders Equity 29

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$6.45K	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$592.13K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$149.40K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$616.90K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.75M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.14M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.24K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.36K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$101.15K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Total assets	`Assets`	$17.52M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$31.02M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	101.23M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	103.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Accounts payable and other current liabilities (including $325,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.69M	USD	Point-in-time
Accounts payable and other current liabilities (including $325,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.82M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$523.26K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.25M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.50M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$597.34K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$480.09K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.54M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.55M	USD	Point-in-time
Commitments and contingencies (See Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (See Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 103,946,048 issued and outstanding at March 31, 2019, and 300,000,000 authorized, 101,226,479 issued and outstanding at March 31, 2018	`CommonStockValue`	$10.40K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 103,946,048 issued and outstanding at March 31, 2019, and 300,000,000 authorized, 101,226,479 issued and outstanding at March 31, 2018	`CommonStockValue`	$10.12K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$95.47M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$79.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.83M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$7.39M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$17.52M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$31.02M	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$977.00K	USD	Annual
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$1.62M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.44M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.72M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.74M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.59M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.84M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.55M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.44M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.26M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.53M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.76M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.98M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.71M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.74M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.55M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$1.92M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$10.52M	USD	Annual
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$14.59M	USD	Annual
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.88M	USD	1 Quarter
General and administrative (including $977,000 and $1,619,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.57M	USD	1 Quarter
Severance expense	`SeveranceCosts1`	$2.47M	USD	1 Quarter
Severance expense	`SeveranceCosts1`	$2.47M	USD	Annual
Total operating expenses	`OperatingExpenses`	$5.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.19M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.08M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$31.78M	USD	Annual
Total operating expenses	`OperatingExpenses`	$19.36M	USD	Annual
Total operating expenses	`OperatingExpenses`	$5.31M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.97M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.72M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.56M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-31.78M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-6.72M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.31M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.56M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-9.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.30M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-19.36M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-7.01M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.08M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.19M	USD	1 Quarter
Warrant modification expense	`WarrantModificationExpense`	$1.29M	USD	1 Quarter
Warrant modification expense	`WarrantModificationExpense`	$1.29M	USD	Annual
Other income, net	`NonoperatingIncomeExpense`	$-3.63K	USD	1 Quarter
Other income, net	`NonoperatingIncomeExpense`	$390.38K	USD	Annual
Other income, net	`NonoperatingIncomeExpense`	$61.12K	USD	1 Quarter
Other income, net	`NonoperatingIncomeExpense`	$-2.43K	USD	1 Quarter
Other income, net	`NonoperatingIncomeExpense`	$27.50K	USD	1 Quarter
Other income, net	`NonoperatingIncomeExpense`	$82.56K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.02M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.20M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.05M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.72M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.56M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.87M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-18.97M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.31M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.98M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-18.97M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-32.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.87M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	102.35M	shares	Annual
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.23M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.26M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	90.57M	shares	Annual
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	103.55M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	103.01M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	93.83M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.32M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.65M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.93M	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	1.09M	shares	Annual
Net loss	`ProfitLoss`	$-18.97M	USD	Annual
Cashless exercise of shares of common stock	`CashlessExerciseOfSharesOfCommonStock`	235,685.00	shares	Annual
Net loss	`ProfitLoss`	$-32.98M	USD	Annual
Depreciation	`Depreciation`	$4.30K	USD	Annual
Depreciation	`Depreciation`	$8.42K	USD	Annual
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$8.56M	USD	Annual
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$7.69M	USD	Annual
Warrant modification expense	`FairValueAdjustmentOfWarrants`	$1.29M	USD	Annual
Severance stock based compensation	`SeveranceStockBasedCompensation`	$388.28K	USD	Annual
Gain on remeasurement of derivative liability	`DerivativeGainLossOnDerivativeNet`	$390.38K	USD	Annual
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$6.45K	USD	Annual
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$337.45K	USD	Annual
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$1.42M	USD	Annual
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$442.73K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-433.33K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-91.55K	USD	Annual
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$654.23K	USD	Annual
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-131.38K	USD	Annual
Severance payable	`IncreaseDecreaseInSeverancePayable`	$2.06M	USD	Annual
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$1.25M	USD	Annual
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$246.56K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.88M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.12M	USD	Annual
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	Annual
Insurance note payments	`InsuranceNotePayments`	$480.09K	USD	Annual
Issuance of common stock from at-the-market financing facility (net of expenses)	`ProceedsFromIssuanceOfCommonStock`	$5.67M	USD	Annual
Issuance of common stock from at-the-market financing facility (net of expenses)	`ProceedsFromIssuanceOfCommonStock`	$5.82M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$270.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$35.53K	USD	Annual
Proceeds from private placement offering of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$2.60M	USD	Annual
Proceeds from the collection of stock subscription receivable	`ProceedsFromCollectionOfStockSubscriptionReceivable`	$175.00K	USD	Annual
Proceeds from public offering, net of issuance of costs	`ProceedsFromIssuanceInitialPublicOffering`	$21.74M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$30.37M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.46M	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$18.49M	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-14.67M	USD	Annual
Cash and cash equivalents beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Cash and cash equivalents end of year	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents end of year	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents end of year	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Interest	`InterestPaidNet`	$7.42K	USD	Annual
Financing of insurance premiums	`FinancingOfInsurancePremiums`	$480.09K	USD	Annual
Financing of insurance premiums	`FinancingOfInsurancePremiums`	$597.34K	USD	Annual
Deferred expenses related to post year end financing	`NoncashDeferredExpensesRelatedToPostYearEndFinancing`	$220.99K	USD	Annual
Derivative liability associated with the price protection feature of shares of common stock issued	`NonCashFairValueofDerivativeLiability`	$11.79K	USD	Annual
Retirement and cancellation of shares of common stock	`RetirementAndCancellationOfSharesOfCommonStock`	$350.00	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$7.39M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$270.00K	USD	Annual
Exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	100,000.00	shares	Annual
Warrant modification	`AdjustmentsToAdditionalPaidInCapitalWarrantModification`	$1.29M	USD	Annual
Severance stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSeveranceStockBasedCompensation`	$388.28K	USD	Annual
Proceeds from collection of stock subscription receivable	`StockholdersEquityOther`	$-175.00K	USD	Annual
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$8.56M	USD	Annual
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.69M	USD	Annual
Issuance of common stock upon exercise of options and warrants	`IssuanceOfCommonStockUponExerciseOfOptionsAndWarrantsValue`	$35.53K	USD	Annual
Derivative liability	`StockIssuedForDerivativeLiability`	$-11.79K	USD	Annual
Net loss	`NetIncomeLoss`	$-18.97M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-32.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.87M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$7.39M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.